VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MNOV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MNOVMediciNova, Inc.
$1.44$71M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMNOVQuarterly Financials

MediciNova, Inc. (MNOV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

MediciNova, Inc. (MNOV) quarterly income statement — complete revenue, gross profit & net income history

MNOV Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue186.98K151.74K123.32K134.6K0000001M000000037.5K0
Revenue Growth %-------100%--------100%--100%---
Cost of Goods Sold174.36K99.98K115.27K116.35K05.18K0005.49K00000006.37K00
COGS % of Revenue93.25%65.89%93.47%86.44%----------------
Gross Profit12.62K51.76K8.05K18.25K0-5.18K000-5.49K1M000000-6.37K37.5K0
Gross Margin %6.75%34.11%6.53%13.56%------100%-------100%-
Gross Profit Growth %-1099.77%---5.74%-100%------100%-100%--100%---
Operating Expenses2.85M3.14M3.39M3.63M3.2M3.18M3.31M3.05M3.14M2.48M2.15M3.3M2.96M3.23M3.9M4.09M3.41M2.1M3.64M4.31M
OpEx % of Revenue1523.35%2072.08%2748.19%2693.44%------214.69%-------9705.17%-
Selling, General & Admin1.59B1.55M1.81M1.44M1.36M1.28M1.45M1.4M1.35M839.33K1.35M1.56M1.49M1.22M1.44M1.52M1.3M325.82K1.55M1.78M
SG&A % of Revenue850433.73%1023.95%1464.55%1067.39%------135.22%-------4135.52%-
Research & Development1.26B1.69M1.58M2.19M1.74M1.91M1.77M1.54M1.64M1.65M701.71K1.64M1.4M2.33M2.36M2.42M2.02M1.77M2M2.53M
R&D % of Revenue675198.95%1114.03%1283.64%1626.05%------70.17%-------5340.31%-
Other Operating Expenses-1000K-100K00100K-5.18K90K107K140K093K97K73K-318.61K90K142K87K086K0
Operating Income-2.84M-3.09M-3.38M-3.61M-3.2M-3.18M-3.31M-3.05M-3.14M-2.49M-1.15M-3.3M-2.96M-3.23M-3.9M-4.09M-3.41M-2.1M-3.6M-4.31M
Operating Margin %-1516.6%-2037.97%-2741.67%-2679.88%-------114.69%--------9605.17%-
Operating Income Growth %11.45%2.87%-2.17%-18.4%-2.12%-27.85%-188.53%7.68%-5.83%22.94%70.57%19.31%13.1%-53.66%-8.2%5.1%-1592.07%30.22%3.43%4.45%
EBITDA-2.79M-3.15M-3.38M-3.6M-3.2M-3.18M-3.3M-3.04M-3.13M-2.48M-1.14M-3.3M-2.96M-3.23M-3.89M-4.09M-3.41M-2.1M-3.59M-4.3M
EBITDA Margin %-1492.64%-2075.7%-2737.37%-2676.12%-------114.12%--------9586.06%-
EBITDA Growth %12.71%0.91%-2.17%-18.44%-2.13%-27.93%-189.52%7.71%-5.8%23%70.69%19.35%13.11%-53.92%-8.3%5.06%-1645.77%30.29%3.49%4.48%
D&A (Non-Cash Add-back)44.81K-57.24K5.3K5.06K5.18K5.18K5.18K5.37K5.35K5.49K5.7K5K4.11K4.33K4.46K4.49K4.43K6.37K7.17K6.15K
EBIT-2.84M-2.8M-3.38M-3.61M-3.2M-3.18M-3.31M-3.05M-3.14M-2.06M-1.15M-3.3M-2.96M-3.23M-3.9M-4.09M-3.41M-2.08M-3.6M-4.31M
Net Interest Income252.96K340.21M340.85K324.95K336.11K390.1K447.85K435.35K397.51K436.26K437.93K451.42K509.05K427.3K253.75K91.28K37.34K36.47K36.15K34.34K
Interest Income252.96K340.21M340.85K324.95K336.11K390.1K447.85K435.35K397.51K436.26K437.93K451.42K509.05K427.3K253.75K91.28K37.34K36.47K36.15K34.34K
Interest Expense00000000000000000000
Other Income/Expense249.55K296.12K330.63K325.91K338.39K374.6K456.95K418.3K381.48K434.07K423.78K428.21K45.74K232.57K245.28K60.94K23.59K22.25K22.77K25.37K
Pretax Income-2.59M-2.8M-3.05M-3.28M-2.86M-2.81M-2.85M-2.63M-2.75M-2.06M-723.11K-2.87M-2.92M-3M-3.65M-4.03M-3.39M-2.08M-3.58M-4.28M
Pretax Margin %-1383.14%-1842.83%-2473.56%-2437.75%-------72.31%--------9544.45%-
Income Tax05.99K0005.54K0003.05K0002.82K0002.57K00
Effective Tax Rate %0%-0.21%0%0%0%-0.2%0%0%0%-0.15%0%0%0%-0.09%0%0%0%-0.12%0%0%
Net Income-2.59M-2.8M-3.05M-3.28M-2.86M-2.81M-2.85M-2.63M-2.75M-2.06M-723.11K-2.87M-2.92M-3M-3.65M-4.03M-3.39M-2.08M-3.58M-4.28M
Net Margin %-1383.14%-1846.78%-2473.56%-2437.75%-------72.31%--------9544.45%-
Net Income Growth %9.7%0.44%-6.95%-24.85%-3.98%-36.69%-294.43%8.48%5.59%31.4%80.2%28.72%13.85%-44.08%-2.04%5.96%-1703.21%30.22%3.37%3.75%
Net Income (Continuing)-2.59M-2.8M-3.05M-3.28M-2.86M-2.81M-2.85M-2.63M-2.75M-2.06M-723.11K-2.87M-2.92M-3M-3.65M-4.03M-3.39M-2.08M-3.58M-4.28M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.05-0.05-0.06-0.07-0.06-0.06-0.06-0.05-0.06-0.04-0.01-0.06-0.06-0.06-0.07-0.08-0.07-0.04-0.07-0.09
EPS Growth %10.1%4.7%-3.09%-24.81%-3.91%-36.67%-295.92%8.53%4.1%31.37%78.85%27.56%14.58%-44%4.92%7.86%-36.47%11.93%12.2%
EPS (Basic)-0.05-0.05-0.06-0.07-0.06-0.06-0.06-0.05-0.06-0.04-0.01-0.06-0.06-0.06-0.07-0.08-0.07-0.04-0.07-0.09
Diluted Shares Outstanding49.22M49.06M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.04M48.99M48.99M48.8M
Basic Shares Outstanding49.22M49.06M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.04M48.99M48.99M48.8M
Dividend Payout Ratio--------------------